Current Location:HomeAbout UsCompany Profile
Healsun Biopharm started its journey by providing stable cell line construction services and has gradually expanded its scope of services to one-stop R&D and production solution for antibodies, fusion proteins, and ADC products from early druggability evaluation, IND pharmaceutical research to commercial production.
After years of dedicated efforts, we have garnered the trust and loyalty of numerous esteemed clients through our excellent service and reputation. We aspire to become a leading CDMO service provider, aiming to provide our clients with the highest quality solutions and support them in achieving remarkable accomplishments in the field of drug development.
Providing clients with comprehensive molecular design and evaluation service, such as protein engineering, activity analysis and druggability analysis based on our high-quality protein production platforms and multiple analytical tools
Self-developed HaoYue® Platform, which can deliver sublicensable stable cell lines with high expression
Process development platforms
2*250 L/500 L GMP manufacturing lines for DS and DP
100 L GMP manufacturing line for ADC DS
6*2000 L commercial-scale manufacturing lines for antibodies
500 L commercial-scale manufacturing line for ADC products
2015
Founded
52500 m²
Area
4
Sites
250+
Employees
Healsun is an highly professional and reliable CDMO. Their expertise in the field is evident in every aspect of their work. From the initial stages of a project to its completion, they demonstrate a high level of competence and commitment. Their reliability is proven through their consistent delivery of quality services. They are a trusted partner for us.
I strongly recommend HealSun Biopharm as a trusted, professional partner. Throughout our collaboration, they consistently demonstrated excellence, transparency, and compliance in development and manufacturing. Their team provided essential support and expert guidance, significantly benefiting our projects. We’re very pleased with their service and look forward to a continued relationship.
Nov.11
Founded
Aug.08
1st CLD Project Obtained IND Approval
Dec.12
Strategic Investment Obtained
Jun.06
New Headquarters Put into Use
Mar.03
Series A Round Completed
1st One-Stop Solution Project Obtained IND Approval
Nov.11
MFG1 Put into Use
Aug.08
Series B Round Completed
Oct.10
Series B+ Round Completed
Q4
MFG2 40000m²
Put into Use
Email:healsunbd@hs-biopharm.com
Copyright © 2023 杭州皓阳生物技术有限公司All Rights Reserved 浙ICP备16013229号-1 浙公网安备 33011002011493号 技术支持:杭州网站制作